Investing.com - 奥本海默在Wave Life Sciences(NASDAQ:WVE)公司公布其1期INLIGHT研究的临床更新后,重申了其跑赢大盘评级和32.00美元的目标价。该目标价相较当前12.30美元的股价显示出上涨潜力,不过InvestingPro数据显示,根据其公允价值分析,该股票目前的估值可能偏高。 该研究评估了WVE-007,其中240毫克剂量组在六个月时显示内脏脂 ...
Investing.com -- Kodiak Sciences Inc. (NASDAQ:KOD)股价周四上涨26%,此前该公司公布了GLOW2的积极顶线结果,这是其针对糖尿病视网膜病变治疗药物Zenkuda(tarcocimab tedromer ...
WVE-007的安全性优势尤为明显,去年12月披露的数据也显示出一定的疗效潜力,但此次更新数据没有看到明确的量效关系,让资本市场对于INHBE siRNA的想象空间和热情有所下降。目前Arrowhead和Wave Life ...
今日,公司正式发布全新英文名称 China Sciences Ecorizon Tech Co., Ltd. , 简称仍为 CSET 。这次更名为更好地契合公司国际化发展需要,是国际化战略落地的关键一步——我们正在从 “深耕中国” 走向 “链接世界” ...
Life sciences organizations should modernize managed services now, focusing on operational readiness, outcome-based models, ...
Joel Mokyr, Philippe Aghion and Peter Howitt have been awarded the 2025 Nobel Prize in Economics. (Photo by Jonathan Nackstrand / AFP) / ALTERNATIVE CROP (Photo by JONATHAN NACKSTRAND/AFP via Getty ...
SHANGHAI, March 21 (Xinhua) -- China on Saturday published a high-quality journal list in the fields of medicine and life sciences, independently compiled by domestic institutions, offering a Chinese ...
The subject area represents the next stage of the database’s evolution, and heralds other proposed changes to journal selection and article categorization. The first Nature Index tables in the applied ...
The clear divergence in approaches to public research funding in the East and West is laid bare in the first Nature Index ranking for applied sciences. China dominates the ranking and other Asian ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果